Literature DB >> 16304261

Elevated oxidative stress and reciprocal reduction of vascular endothelial growth factor levels with severity of COPD.

Hiroshi Kanazawa1, Junichi Yoshikawa.   

Abstract

STUDY
OBJECTIVES: The prevalent theory concerning the pathogenesis of COPD is that it is an imbalance between oxidants and antioxidants. However, it has been reported that a decrease in vascular endothelial growth factor (VEGF) might affect the pathogenesis of COPD. Therefore, this study was designed to examine the differences between oxidative stress and VEGF levels, and the severity of COPD.
DESIGN: Controlled cross-sectional analysis.
SETTING: University hospital. PARTICIPANTS: Twelve healthy control subjects and 57 COPD patients were included in this study. These COPD patients were divided into four groups based on the Global Initiative for Chronic Obstructive Lung Disease classification (mild COPD, 14 patients; moderate COPD, 15 patients; severe COPD, 16 patients; very severe COPD, 12 patients). MEASUREMENTS AND
RESULTS: Inflammatory markers, degree of oxidative stress, and VEGF levels were examined in sputum samples from all subjects. Nitrogen oxide levels in induced sputum were significantly higher in COPD patients than in healthy control subjects, and they increased with increases in the severity of COPD. In contrast, peroxynitrite inhibitory activity decreased with increases in the severity of COPD. Therefore, the mean (SD) peroxynitrite stress (ie, the nitrogen oxide level/peroxynitrite inhibitory activity ratio) steeply increased with increases in the severity of COPD (mild COPD: 8.4; SD, 1.5; p = 0.02; moderate COPD: 10.8; SD, 1.4; p < 0.0001; severe COPD: 14.5; SD, 2.5; p < 0.0001; very severe COPD: 18.3; SD, 4.1; p < 0.0001) compared with that of healthy control subjects. VEGF levels in induced sputum reciprocally decreased with severity of COPD (mild COPD: 1,360 pg/mL; SD, 800 pg/mL; p = 0.97; moderate COPD: 1,180 pg/mL; SD, 760 pg/mL; p = 0.50; severe COPD: 650 pg/mL; SD, 450 pg/mL; p = 0.007; very severe COPD: 480 pg/mL, SD, 240 pg/mL; p = 0.002). In addition, peroxynitrite inhibitory activity in COPD patients exhibited an accelerated decline from the mean VEGF level in healthy control subjects.
CONCLUSIONS: Elevated oxidative stress levels and a reciprocal reduction of VEGF levels in induced sputum were prominent with increases in the severity of COPD. Thus, epithelial cell injury mediated by oxidative stress may induce the decrease in lung VEGF levels, resulting in the promotion of the development of COPD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16304261     DOI: 10.1378/chest.128.5.3191

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  23 in total

1.  Coactivator-Associated Arginine Methyltransferase-1 Function in Alveolar Epithelial Senescence and Elastase-Induced Emphysema Susceptibility.

Authors:  Rim S J Sarker; Gerrit John-Schuster; Alexander Bohla; Kathrin Mutze; Gerald Burgstaller; Mark T Bedford; Melanie Königshoff; Oliver Eickelberg; Ali Ö Yildirim
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

2.  Macrophage Migration Inhibitory Factor: A Novel Inhibitor of Apoptosis Signal-Regulating Kinase 1-p38-Xanthine Oxidoreductase-Dependent Cigarette Smoke-Induced Apoptosis.

Authors:  Jonathan Fallica; Lidenys Varela; Laura Johnston; Bo Kim; Leonid Serebreni; Lan Wang; Mahendra Damarla; Todd M Kolb; Paul M Hassoun; Rachel Damico
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

3.  Apoptosis of alveolar wall cells in chronic obstructive pulmonary disease patients with pulmonary emphysema is involved in emphysematous changes.

Authors:  Hongmei Liu; Lijun Ma; Jizhen Wu; Kai Wang; Xianliang Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

4.  sJIVE: Supervised Joint and Individual Variation Explained.

Authors:  Elise F Palzer; Christine H Wendt; Russell P Bowler; Craig P Hersh; Sandra E Safo; Eric F Lock
Journal:  Comput Stat Data Anal       Date:  2022-06-14       Impact factor: 2.035

5.  Macrophage migration inhibitory factor is a novel determinant of cigarette smoke-induced lung damage.

Authors:  Jonathan Fallica; Laurent Boyer; Bo Kim; Leonid Serebreni; Lidenys Varela; Omar Hamdan; Lan Wang; Tiffany Simms; Mahendra Damarla; Todd M Kolb; Richard Bucala; Wayne Mitzner; Paul M Hassoun; Rachel Damico
Journal:  Am J Respir Cell Mol Biol       Date:  2014-07       Impact factor: 6.914

Review 6.  Molecular pathogenesis of emphysema.

Authors:  Laimute Taraseviciene-Stewart; Norbert F Voelkel
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

7.  Defect of adaptation to hypoxia in patients with COPD due to reduction of histone deacetylase 7.

Authors:  Masako To; Satoshi Yamamura; Kenichi Akashi; Catherine E Charron; Kosuke Haruki; Peter J Barnes; Kazuhiro Ito
Journal:  Chest       Date:  2011-12-15       Impact factor: 9.410

8.  Increased expression of placenta growth factor in COPD.

Authors:  S-L Cheng; H-C Wang; C-J Yu; P-C Yang
Journal:  Thorax       Date:  2008-01-17       Impact factor: 9.139

Review 9.  Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema.

Authors:  Ingel K Demedts; Tine Demoor; Ken R Bracke; Guy F Joos; Guy G Brusselle
Journal:  Respir Res       Date:  2006-03-30

10.  Vascular endothelial growth factor as a non-invasive marker of pulmonary vascular remodeling in patients with bronchitis-type of COPD.

Authors:  Hiroshi Kanazawa; Kazuhisa Asai; Saeko Nomura
Journal:  Respir Res       Date:  2007-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.